Edition:
United States

Tenax Therapeutics Inc (TENX.OQ)

TENX.OQ on NASDAQ Stock Exchange Capital Market

0.34USD
16 Feb 2018
Change (% chg)

$-0.01 (-2.95%)
Prev Close
$0.36
Open
$0.36
Day's High
$0.36
Day's Low
$0.34
Volume
42,065
Avg. Vol
67,315
52-wk High
$0.84
52-wk Low
$0.30

Select another date:

Tue, Jan 16 2018

BRIEF-Tenax Therapeutics Announces Plan To Develop Levosimendan For A Pulmonary Hypertension Indication With No FDA Approved Therapies

* TENAX THERAPEUTICS ANNOUNCES PLAN TO DEVELOP LEVOSIMENDAN FOR A PULMONARY HYPERTENSION INDICATION WITH NO FDA APPROVED THERAPIES

Select another date: